Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.4125 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.2745 | 0.2745 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0041 | 0.2745 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4125 | 0.4125 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.4125 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.2976 | 0.2976 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2976 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.4125 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0116 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.4125 | 1 |
Onchocerca volvulus | 0.0103 | 0.8745 | 0.8745 | |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2976 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.2976 | 0.7216 |
Toxoplasma gondii | kringle domain-containing protein | 0.0041 | 0.2745 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0041 | 0.2745 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.4125 | 0.4125 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0041 | 0.2745 | 0.6654 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.2976 | 0.7216 |
Brugia malayi | Protein kinase domain containing protein | 0.0041 | 0.2745 | 0.2745 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0116 | 1 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0041 | 0.2745 | 0.2745 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2976 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4125 | 0.4125 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0041 | 0.2745 | 0.6654 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.2745 | 0.2745 |
Onchocerca volvulus | 0.0041 | 0.2745 | 0.2745 | |
Onchocerca volvulus | 0.0116 | 1 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2976 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.2745 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.0041 | 0.2745 | 0.2745 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0041 | 0.2745 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.2976 | 0.2976 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.4125 | 0.4125 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.2976 | 0.2976 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4125 | 0.4125 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.5821 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.